Synthesis and transport properties of [Ni 3 Sn][Ni 4− x S 2 ], an n-type metal-rich sulfide with an intergrowth structure
Chemical Communications · 2025 · 61 (66) · 12321-12324
DOI: 10.1039/d5cc03147h ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemical Communications, 2025. Verfasst von Laura Agnarelli und 3 weiteren Autor:innen. Beteiligte Einrichtung: Laboratoire CRISMAT, UMR 6508 CNRS/ENSICAEN/UNICAEN/Normandie Université, 6 bd du Maréchal Juin, F-14050 CAEN Cedex 4, France. laura.agnarelli@ensica…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Gefördert von: Agence Nationale de la Recherche.
Abstract (Originalsprache)
Synthesis, structural and transport properties of Ni 7− δ SnS 2 : signatures of structural modulation were evidenced by TEM and the intergrowth structure leads to a moderate value of thermal conductivity in this metal-rich sulfide.
Autor:innen und Institutionen
- Laboratoire CRISMAT, UMR 6508 CNRS/ENSICAEN/UNICAEN/Normandie Université, 6 bd du Maréchal Juin, F-14050 CAEN Cedex 4, France. laura.agnarelli@ensicaen.fr.
Förderung
- Agence Nationale de la Recherche
Zitieren
APA
Agnarelli, L., Pelloquin, D., Maignan, A., & Hébert, S. (2025). Synthesis and transport properties of [Ni 3 Sn][Ni 4− x S 2 ], an n-type metal-rich sulfide with an intergrowth structure. Chemical Communications, 61(66), 12321-12324. https://doi.org/10.1039/d5cc03147h
Vancouver
Agnarelli L, Pelloquin D, Maignan A, Hébert S. Synthesis and transport properties of [Ni 3 Sn][Ni 4− x S 2 ], an n-type metal-rich sulfide with an intergrowth structure. Chemical Communications. 2025;61(66):12321-12324. doi:10.1039/d5cc03147h
BibTeX
@article{Agnarelli2025,
author = {Agnarelli, Laura and Pelloquin, Denis and Maignan, Antoine and Hébert, Sylvie},
title = {Synthesis and transport properties of [Ni 3 Sn][Ni 4− x S 2 ], an n-type metal-rich sulfide with an intergrowth structure},
journal = {Chemical Communications},
year = {2025},
volume = {61},
number = {66},
pages = {12321--12324},
doi = {10.1039/d5cc03147h}
}
EUVIMED